Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
株式のランク #30394
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
株価
$0.03834
最終同期: 2026-08-18
時価総額
$17.01M
変化(1日)
-4.15%
変化(1年)
-24.82%
US
取引 Oncotelic Therapeutics, Inc. (OTLC)

カテゴリー

Oncotelic Therapeutics, Inc.(OTLC)の株価履歴
終値の最高値: $0.04 (2026-08-01)

終値の最安値: $1.13K (1993-08-01)
Oncotelic Therapeutics, Inc. の株価履歴(1993 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -32.69%
2025 190.53%
2024 -20.32%
2023 -22.41%
2022 -69.52%
2021 -23.89%
2020 10.12%
2019 94.22%
2018 -42.06%
2017 -52.99%
2016 -55.78%
2015 -50.20%
2014 -33.92%
2013 -46.34%
2012 -62.10%
2011 -75.63%
2010 -81.77%
2009 63.41%
2008 -70.61%
2007 -50.93%
2006 16.57%
2005 -22.97%
2004 -35.60%
2003 628.33%
2002 -57.82%
2001 -63.45%
2000 -53.89%
1999 80.93%
1998 -47.29%
1997 -25.80%
1996 133.79%
1995 86.60%
1994 -25.42%
1993 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.89 35.09%
US
$996.61 51.72%
NL
$115.52 -20.64%
AU
$735.86 6.07%
CH
$257.75 14.92%
BE